ARS Pharmaceuticals Inc

Research ARS Pharmaceuticals Inc (SPRY) on Bullrun: market cap USD 850.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSPRY
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 850.04M
• Financial periodFY2025
• RevenueUSD 84.28M
• Revenue growth-5.5%
• Net income-USD 171.30M
• Free cash flow-USD 171.21M

Valuation Snapshot

latest market cap is USD 850.04M.

About ARS Pharmaceuticals Inc

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Frequently asked questions

What is ARS Pharmaceuticals Inc's market cap?

ARS Pharmaceuticals Inc's market capitalization is USD 850.04M.

What does ARS Pharmaceuticals Inc do?

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.